Physician profile
Thomas Callahan
NPI 1508809138
$707.20
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.76 · 2022: $229 · 2023: $44.81 · 2024: $208 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $179.23 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $159.64 | 2024 | Concertotm, Mvp |
| Terumo Medical Corporation | $105.36 | 2022 | |
| Cardinal Health 200 LLC | $61.64 | 2019 | |
| Boston Scientific Corporation | $48.20 | 2022 | |
| Angiodynamics, INC. | $47.70 | 2022-2023 | Bioflo |
| Inari Medical, INC. | $25.56 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Trisalus Life Sciences, INC. | $24.26 | 2024 | Trinav Infusion System |
| Cook Medical LLC | $23.67 | 2024 | Zilver Ptx |
| Penumbra, INC. | $20.82 | 2022 | |
| Rigel Pharmaceuticals, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Callahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.